Symposium: The Gut Microbiota and Disease - Session I

Symposium: The Gut Microbiota and Disease - Session I

Tuesday, April 27, 2021 • 8:30 AM - 11:30 AM (EST)

 

Xiao-Ming Yin, MD, PhDChair
Xiao-Ming Yin, MD, PhD
Indiana University School of Medicine

Wenke Feng, PhDCo-Chair
Wenke Feng, PhD
University of Louisville

Maria Pilar Alcaide, PhDCo-Chair
Maria Pilar Alcaide, PhD
Tufts University School of Medicine

Jose Otero, MD, PhDCo-Chair
José Otero, MD, PhD
The Ohio State University

Session Description: Humans carry a vast number of bacteria and other microbiota species from birth, and you may be more bacteria than you are you.  An increasing importance of microbiota in human health and diseases has been recognized.  Whatever your research subjects are, chances are that they may be influenced by the microbiota.  This symposium will discuss the impact of gut microbiota on diseases ranging from neurodegeneration to diabetes, from the liver to the heart, and from the immune cells to the bone.

  • Chair - Welcome and Introductions
  • 8:30 AM - 9:00 AM
    Gut Microbiota, Bile Acids Receptor, and Metabolism
    John YL Chiang, PhD • Northeast Ohio Medical University
  • 9:05 AM - 9:35 AM
    Hepatic Autophagy, Microbiota, and Liver Injury
    Xiao-Ming Yin, MD, PhD • Indiana University
  • 9:40 AM - 10:10 AM
    Gut Microbiota, Fatty Liver Disease, and Hepatocellular Carcinoma
    Bernd Schnabl, MD • University of California, San Diego
  • 10:15 AM - 10:45 AM
    Intestinal Barrier Function and Metabolic Liver Disease
    Wenke Feng, PhD • University of Louisville
  • 10:50 AM - 11:20 AM
    Fecal Transplantation and Immune Regulation in Liver Disease
    Shirish Barve, PhD • University of Louisville
  • 11:25 AM - 11:30 AM
    Closing Remarks